Review

[Update guide on pediatric multiple sclerosis].

Rocío R. García Andrea Quiroz Saavedra Sandra Jimenez Alex S. Aguirre Elizabeth Wilson Denis López Alfredo Cerisola E. Andrade María Teresa Acosta J. Vidaurre A. Savransky

Aug 2026 · Medicina · Vol 86 Suppl 3, pp. 172-176 · 0 citations

Medicine

TL;DR

Evidence indicates that early initiation of high-efficacy disease-modifying therapies is associated with improved long-term outcomes.

PubMed Semantic Scholar

View source

Similar papers

Review Sep 2026

Pediatric multiple sclerosis: a diagnostic overview and the importance of early identification

This review summarizes the diagnostic work-up of children with a first acquired demyelinating syndrome, differential diagnosis, the role of MRI, cerebrospinal fluid (CSF) markers, antibody testing, serum neurofilament light chain, optical pathway assessment and the 2024 McDonald criteria.

M. Margoni, Massimo Filippi, M. Rocca · Expert Review of Neurotherap... · 0 citations

Open access Sep 2026

Late-onset versus adult-onset multiple sclerosis: A comparative analysis of clinical, radiological, and confirmed disability progression.

BACKGROUND Multiple sclerosis (MS) is a chronic, immune-mediated disorder of the central nervous system (CNS). In Egypt, its occurrence is approximately 13.7 per 100,000 inhabitants. The average age of onset for relapsing-remitting MS (RRMS) is between the second and fourth decades of life. OBJECTIVES To determine th...

A. Fouad, Abdallah Saad, Hadeer Mohamed Abd El-Aziz et al. · Multiple Sclerosis and Relat... · 0 citations

Review Sep 2026

Recognition and management of acute relapse of multiple sclerosis, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.

The clinical patterns of acute attacks and relapses of multiple sclerosis, NMOSD and MOGAD are discussed, including the clinical and para-clinical modalities that are critical for timely recognition and diagnosis, and available evidence regarding treatment selection and responsiveness is presented.

Yu-Jing Li, Wei Jiang, Chao Zhang et al. · Cell Death and Differentiati... · 0 citations

Review Open access Sep 2026

Management of Multiple Sclerosis: Incorporating Recent Advances in Pathophysiology and Diagnosis to Guide Treatment Strategies.

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disorder of the central nervous system for which more than 20 disease-modifying therapies (DMTs) are currently available. Recent advances in diagnostic criteria, biomarker development, and understanding of disease biology have challenged traditiona...

Moein Amin, Kaitlyn N. Palmer, A. Samara et al. · Drugs · 0 citations

Review Sep 2026

Advancement and Challenges in Multiple Sclerosis: Understanding the Disease from Etiology to Treatment.

Multiple Sclerosis (MS) is a chronic immune-mediated neurodegenerative disorder of the Central Nervous System (CNS) that affects more than 2.8 million people worldwide. It is recognized as one of the leading causes of non-traumatic neurological disability among young adults. It is an inflammatory demyelination disease...

K. Ravi, K. Arora · Current Neurovascular Resear... · 0 citations

Review Open access Aug 2026

Modern diagnosis and treatment of multiple sclerosis: advances, challenges, and future directions.

Key updates include expansion of dissemination in space to incorporate the optic nerve, integration of relapsing and progressive onset MS within a unified diagnostic framework, provision for diagnosis in selected asymptomatic individuals, dispensing with the requirement for dissemination of time in certain situations a...

P. Siriratnam, Mineesh Datta, Katherine A. Buzzard et al. · Autoimmunity Reviews · 0 citations